Latest Revenue Growth News

Globe International reported a 3.1% revenue increase to $98.2 million for the half-year ended December 2025, despite a 27% drop in EBIT due to unexpected US tariffs. The company maintains its interim dividend, signalling steady shareholder returns amid geopolitical challenges.

StepChange Holdings Limited reports a strong half-year performance post-IPO, with $24.36 million in revenue and a net profit of $524,400, underpinned by key acquisitions and US expansion.

NTAW Holdings reported a reduced half-year loss of $9.7 million on a 12.3% revenue decline, driven by operational challenges and brand distribution changes. The company is focusing on cost restructuring and strategic partnerships to restore growth.

Camplify Holdings Limited reported a significant 62.5% reduction in net loss for H1 FY26, alongside a modest revenue dip and a strong cash position, driven by operational efficiencies and a pivot to higher-margin membership products.

Streamplay Studio Limited reports a strong half-year turnaround with an 85% revenue surge and a $571K profit, driven by the Noodlecake acquisition and a blockbuster game launch.

K2 Asset Management reported a 9% revenue increase and a 7% rise in assets under management, positioning itself for a return to profitability in the 2026 financial year.

SenSen Networks has reported a 20.2% increase in revenue for the half-year ended December 2025, alongside a significant reduction in net loss, driven by new customer wins and expanding North American operations.

Clinuvel Pharmaceuticals reported a 4% increase in revenue to A$36.93 million for the half year ended December 2025, despite a 26% drop in profit after tax due to higher expenses supporting growth initiatives. The company maintains a robust cash position of A$233 million and is progressing key clinical trials and regulatory milestones.

Farm Pride Foods Limited reported a remarkable 409% surge in net profit to $8.295 million for H1 FY2026, driven by a 40% increase in revenues and operational efficiencies. The company also advanced major capital projects to support future growth.

Bioxyne Limited has reported a remarkable half-year performance, with revenues soaring 149% to $31.3 million and net profit more than doubling to $7.3 million, driven by strong demand for medicinal cannabis, MDMA, and psilocybin products and expanding international operations.

Atomo Diagnostics has reported a significant narrowing of its half-year loss, driven by a 6% increase in revenue and a 35% reduction in operating expenses. The company’s strategic focus on cost management and expanding its diagnostic platforms underpins a cautiously optimistic outlook.

Ambertech Limited posted a 7% revenue increase to $48.5 million in 1H FY26 but reported a $2.6 million net loss after one-off impairments. The company is embarking on a strategic reset to restore profitability and improve capital efficiency.